Under the FD&C Act, what is the minimum period for which a brand-name drug manufacturer must provide patent and exclusivity information listed in the 'Orange Book'?
-
A
The duration of the patent or exclusivity period as applicable
-
B
5 years from date of NDA approval regardless of patent
-
C
3 years for all new drug products
-
D
10 years for biologics, 5 years for small molecules